DexCom (DXCM) Misses Q1 EPS by 1c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $90.74 -0.07%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.01 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.6 billion, versus the consensus of $4.606 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sandisk targets mid-to-high teens revenue growth through FY2030
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
